$4.44
+
$0.11 (2.54%)
End-of-day quote: 05/14/2024
NasdaqCM:CELZ
Creative Medical Technology Holdings Annual Report
| Year | Year | 2023 | 2022 | ||
|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.01M | $0.09M | |
| GM % | Gross Margin % |
|
60.00% | 67.84% | |
| OM | Operating Margin |
|
0.00% | 0.00% | |
| EPS | Earnings Per Share |
|
$0.00 | $-3.76 | $-9.30 |
| Div. | Dividends |
|
$0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
0 | 0 | |
| Sha. | Shares |
|
1.37m | 1.41m | |
| OCF | Operating Cash Flow |
|
$-8.03M | $-7.80M | |
| FCF | Free Cash Flow |
|
$0.00M | $0.00M | |
| FCFS | Free Cash Flow Per Share |
|
$-5.77 | $-7.13 |
